Operating Expenses
Stock-Based Compensation Expense
HCA Healthcare Stock-Based Compensation Expense decreased by 14.0% to $86.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.2%, from $98.00M to $86.00M. Over 4 years (FY 2021 to FY 2025), Stock-Based Compensation Expense shows relatively stable performance with a -2.3% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
First reportedQ1 2013
Last reportedQ1 2026Apr 29, 2026
Metric ID:
adi_stock_based_compensationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $129.00M | $115.00M | $99.00M | $86.00M | $85.00M | $87.00M | $83.00M | $77.00M | $56.00M | $72.00M | $57.00M | $87.00M | $112.00M | $76.00M | $85.00M | $98.00M | $99.00M | $104.00M | $100.00M | $86.00M |
| QoQ Change | — | -10.9% | -13.9% | -13.1% | -1.2% | +2.4% | -4.6% | -7.2% | -27.3% | +28.6% | -20.8% | +52.6% | +28.7% | -32.1% | +11.8% | +15.3% | +1.0% | +5.1% | -3.8% | -14.0% |
| YoY Change | — | — | — | — | -34.1% | -24.3% | -16.2% | -10.5% | -34.1% | -17.2% | -31.3% | +13.0% | +100.0% | +5.6% | +49.1% | +12.6% | -11.6% | +36.8% | +17.6% | -12.2% |
Range$56.00M – $129.00M
CAGR-8.2%
Avg YoY Growth+2.7%
Median YoY Growth-11.0%
Current Streak2 quarters decline
Stock-Based Compensation Expense at Other Companies
Frequently Asked Questions
- What is HCA Healthcare's stock-based compensation expense?
- HCA Healthcare (HCA) reported stock-based compensation expense of $86.00M in Q1 2026.
- How has HCA Healthcare's stock-based compensation expense changed year-over-year?
- HCA Healthcare's stock-based compensation expense decreased by 12.2% year-over-year, from $98.00M to $86.00M.
- What is the long-term trend for HCA Healthcare's stock-based compensation expense?
- Over 4 years (2021 to 2025), HCA Healthcare's stock-based compensation expense has grown at a -2.3% compound annual growth rate (CAGR), from $440.00M to $401.00M.